MOTS-c Research: The Mitochondrial-Derived Peptide Explained

MOTS-c research sits at an unusual crossroads: it concerns a peptide whose coding sequence lives not in the nuclear genome but in mitochondrial DNA. This article explains how MOTS-c was discovered, the biochemical route by which it is thought to engage AMP-activated protein kinase (AMPK), what cell and rodent studies have observed, and which experimental questions remain open for laboratories working with the MOTS-c peptide.

A peptide hidden in a ribosomal RNA gene

Mitochondrial DNA was long regarded as a closed system encoding 13 respiratory-chain polypeptides, 22 tRNAs and two rRNAs. The discovery of humanin in the early 2000s showed that short open reading frames (sORFs) inside the rRNA genes can yield bioactive peptides, and the category of "mitochondrial-derived peptides" grew from there.

In 2015, Lee and colleagues screened the 12S rRNA gene (MT-RNR1) for sORFs and identified one encoding a 16-residue peptide they named MOTS-c, for mitochondrial open reading frame of the 12S rRNA type-c [1]. The sequence is MRWQEMGYIFYPRKLR. Several features make it experimentally interesting:

• It carries a net positive charge from its arginine and lysine residues, a property shared with many membrane-interacting peptides.
• Endogenous MOTS-c has been reported in skeletal muscle and in circulation, which is why it is discussed as a possible signaling molecule rather than a purely intracellular product [1, 4].
• Whether it is translated inside the mitochondrion or exported and translated on cytosolic ribosomes is still debated, because mitochondrial and cytosolic genetic codes differ at several codons.

That last point matters for anyone designing expression constructs: a synthetic peptide sidesteps the translation question entirely, which is one reason most mechanistic work uses chemically synthesized material.

The one-carbon metabolism and AICAR connection

The most cited mechanistic proposal came from the same 2015 paper. In HEK293 cells, MOTS-c overexpression or exogenous peptide altered the metabolome in a pattern consistent with inhibition of one-carbon (folate) metabolism and de novo purine synthesis [1]. The key intermediate was 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR, as its monophosphate ZMP), which rose in treated cells.

ZMP is an AMP analog that binds the regulatory γ-subunit of AMPK. Its accumulation offers a coherent explanation for the AMPK activation the authors observed downstream of the metabolic shift [1]. The link means that MOTS-c studies and studies using exogenous AICAR share a common readout, and our overview of AICAR and AMPK activation covers the pharmacology of ZMP in more detail.

Observations in mice

In the same study, C57BL/6 mice fed a high-fat diet and given the peptide showed less diet-associated weight gain and preserved insulin sensitivity compared with controls, with skeletal muscle identified as a principal target tissue [1]. A later mouse study combined MOTS-c exposure with a treadmill-training paradigm and reported increased PGC-1α expression and AMPK pathway activity in muscle, alongside improved glucose handling in the mouse model [2]. Both studies are rodent observations and should be read as such; dose-response relationships and pharmacokinetics in these models were not characterized in depth.

Nuclear translocation: a retrograde signal

A second line of work asked where MOTS-c goes inside the cell. Kim and colleagues reported in 2018 that under glucose restriction, serum deprivation or oxidative stress, MOTS-c translocates from the cytoplasm to the nucleus in an AMPK-dependent manner [3]. Once there, it associated with chromatin and influenced transcription of genes carrying antioxidant response elements (ARE), in cooperation with the transcription factor NRF2.

This finding reframed MOTS-c as a candidate mitochondrial-to-nuclear (retrograde) messenger. The proposed sequence of events is:

1. Metabolic stress activates AMPK.
2. AMPK activity permits nuclear entry of MOTS-c.
3. Nuclear MOTS-c binds chromatin at stress-responsive loci.
4. NRF2/ARE target genes shift in expression, altering the cell's adaptive profile.

Because the model depends on the peptide reaching chromatin, scrambled-sequence controls and point mutants are useful tools for testing which residues govern localization in a given cell system.

Exercise physiology and aged-mouse studies

Reynolds and colleagues extended the work in 2021, reporting that endogenous MOTS-c levels in skeletal muscle and circulation rose after exercise in human sampling, and treating mice at different ages with the synthetic peptide [4]. In young, middle-aged and old mice, they reported changes in physical-capacity measures, and in cultured myoblasts they described effects on nuclear genes linked to metabolism and proteostasis and on adaptation to metabolic stress. The paper is notable for combining endogenous measurements with interventional mouse experiments, but its interventional arms were confined to rodents.

Across these papers, the common threads are AMPK engagement, skeletal muscle as a responsive tissue, and a stress-conditioned change in the peptide's subcellular location.

Designing MOTS-c experiments: practical considerations

Research groups entering this area tend to encounter the same technical issues.

Consideration	Why it matters	Practical approach
Peptide identity	A 16-mer with Met at both termini is prone to oxidation	Confirm mass by LC-MS; watch for +16 Da oxidized species
Solubility	Cationic, but the YIF core adds hydrophobicity	Prepare concentrated aqueous stocks, aliquot, and avoid repeated freeze-thaw
Endogenous detection	Antibody specificity has varied between labs	Include peptide-competition controls and, where possible, MS-based quantification
Pathway attribution	AMPK can be activated by many stressors	Measure ZMP directly, and use AMPK-deficient cells or scrambled peptide controls

Methionine oxidation deserves emphasis. A mass shift of +16 Da on a certificate of analysis or in your own LC-MS run indicates Met-sulfoxide, which could alter activity. Our explainer on mass spectrometry and peptide identity confirmation describes how to read those spectra, and batch-level CoAs for our catalog are posted on the lab reports page.

Choosing readouts

A defensible MOTS-c experiment usually pairs a proximal readout with a distal one:

• Proximal: phospho-AMPKα (Thr172) and phospho-ACC (Ser79) by western blot; intracellular ZMP by LC-MS.
• Distal: glucose uptake (2-deoxyglucose), oxygen consumption by extracellular flux analysis, or ARE-luciferase reporters for the nuclear arm of the pathway.
• Localization: fractionation or immunofluorescence under basal versus nutrient-deprived conditions, to test the translocation model.

Open questions in the literature

Several points remain unsettled and are worth flagging when interpreting published work:

• Receptor or transporter? No cell-surface receptor has been identified. How exogenous MOTS-c enters cells is not fully characterized.
• Translation site. The mitochondrial versus cytosolic translation question affects how endogenous MOTS-c levels should be interpreted.
• Assay harmonization. Circulating concentrations reported by ELISA have varied, and cross-lab comparisons are difficult without MS-based reference methods.
• Relationship to other mitochondrial-derived peptides. Humanin and the SHLP family share origin but not sequence; whether their signaling overlaps is still being mapped.

For laboratories comparing MOTS-c with other mitochondrial-focused tools, our article on SS-31 and cardiolipin describes a peptide that acts on the inner membrane itself rather than through a nuclear signal.

Key takeaways

• MOTS-c is a 16-residue peptide encoded by a short open reading frame in the mitochondrial 12S rRNA gene [1].
• Cell studies link it to inhibition of one-carbon metabolism, ZMP (AICAR) accumulation and AMPK activation [1].
• Under metabolic stress, MOTS-c was reported to enter the nucleus and regulate NRF2/ARE target genes [3].
• Mouse studies have examined high-fat-diet, exercise-training and aged-animal paradigms [1, 2, 4]; these are rodent observations.
• Methionine oxidation and antibody specificity are the most common technical pitfalls.

This article summarizes published research for informational purposes. All Ascent Sciences products are for laboratory research use only and are not for human or animal consumption.

References

1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454. PubMed
2. Yang B, Yu Q, Chang B, et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochimica et Biophysica Acta Molecular Basis of Disease. 2021;1867(6):166126. PubMed
3. Kim KH, Son JM, Benayoun BA, Lee C. The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Cell Metabolism. 2018;28(3):516-524.e7. PubMed
4. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021;12(1):470. PubMed